Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Depreciation & Amortization (CF) (2020 - 2025)

Maravai Lifesciences Holdings has reported Depreciation & Amortization (CF) over the past 6 years, most recently at $6.0 million for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $6.0 million for Q4 2025, up 8.36% from a year ago — trailing twelve months through Dec 2025 was $23.6 million (up 12.92% YoY), and the annual figure for FY2025 was $23.6 million, up 12.92%.
  • Depreciation & Amortization (CF) for Q4 2025 was $6.0 million at Maravai Lifesciences Holdings, roughly flat from $6.0 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for MRVI hit a ceiling of $6.0 million in Q3 2025 and a floor of $1.3 million in Q1 2021.
  • Median Depreciation & Amortization (CF) over the past 5 years was $3.4 million (2023), compared with a mean of $3.6 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): decreased 25.72% in 2021 and later skyrocketed 130.1% in 2024.
  • Maravai Lifesciences Holdings' Depreciation & Amortization (CF) stood at $1.7 million in 2021, then increased by 12.44% to $2.0 million in 2022, then soared by 100.41% to $3.9 million in 2023, then surged by 40.23% to $5.5 million in 2024, then increased by 8.36% to $6.0 million in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $6.0 million (Q4 2025), $6.0 million (Q3 2025), and $6.0 million (Q2 2025) per Business Quant data.